PMID- 19652426 OWN - NLM STAT- MEDLINE DCOM- 20091104 LR - 20220408 IS - 1349-7235 (Electronic) IS - 0918-2918 (Linking) VI - 48 IP - 15 DP - 2009 TI - Production of inflammatory mediators by monocytes in patients with obstructive sleep apnea syndrome. PG - 1255-62 AB - BACKGROUND: Obstructive sleep apnea syndrome (OSAS) is known to be a risk factor of cardiovascular events. However, the precise mechanism linking the two has not been fully elucidated. OBJECTIVE: The aim of this study was to investigate the effect of hypoxic stress on the production of tumor necrosis factor (TNF)-alpha, monocyte chemoattractant protein-1 (MCP-1), and matrix metalloproteinase-9 (MMP-9) by monocytes. METHODS: Thirty-three OSAS patients and 13 healthy control subjects were enrolled. The OSAS patients were classified as mild-to-moderate (13) and severe (20). Venous blood samples were collected before and after sleep as well as after long-term nasal continuous positive airway pressure (CPAP) treatment for the purpose of isolation of monocytes. Peripheral blood monocytes were isolated using standard methods. Monocytes were cultured under lipopolysaccharide stimulation for 24 hours, and TNF-alpha, MCP-1, and MMP-9 in the culture supernatants were determined by ELISA. RESULTS: In severe patients, the TNF-alpha production by monocytes was significantly elevated as compared to that before sleep (p<0.01). In all OSAS patients, the TNF-alpha production after sleep was significantly correlated with AHI (p<0.01), ODI (p<0.01) and % time in SpO(2)<90% (p<0.05), and inversely correlated with the lowest SpO(2) (p<0.01). The production of MCP-1 and MMP-9 by monocytes was significantly elevated compared to that before sleep in severe patients (p<0.05). The production of these mediators by monocytes was significantly decreased after long-term nasal CPAP treatment (p<0.05). CONCLUSION: These results indicate that OSAS-induced hypoxic stress activates the production of inflammatory mediators by monocytes. FAU - Tamaki, Shinji AU - Tamaki S AD - Second Department of Internal Medicine, Nara Medical University, Nara. FAU - Yamauchi, Motoo AU - Yamauchi M FAU - Fukuoka, Atsuhiko AU - Fukuoka A FAU - Makinodan, Kiyoshi AU - Makinodan K FAU - Koyama, Noriko AU - Koyama N FAU - Tomoda, Koichi AU - Tomoda K FAU - Yoshikawa, Masanori AU - Yoshikawa M FAU - Kimura, Hiroshi AU - Kimura H LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20090803 PL - Japan TA - Intern Med JT - Internal medicine (Tokyo, Japan) JID - 9204241 RN - 0 (CCL2 protein, human) RN - 0 (Chemokine CCL2) RN - 0 (Inflammation Mediators) RN - 0 (Tumor Necrosis Factor-alpha) RN - EC 3.4.24.35 (Matrix Metalloproteinase 9) SB - IM MH - Adult MH - Body Mass Index MH - Case-Control Studies MH - Chemokine CCL2/biosynthesis MH - Continuous Positive Airway Pressure MH - Female MH - Humans MH - Hypoxia/metabolism MH - In Vitro Techniques MH - Inflammation Mediators/*metabolism MH - Male MH - Matrix Metalloproteinase 9/biosynthesis MH - Middle Aged MH - Monocytes/*metabolism MH - Sleep Apnea, Obstructive/*metabolism/pathology/therapy MH - Stress, Physiological MH - Time Factors MH - Tumor Necrosis Factor-alpha/biosynthesis EDAT- 2009/08/05 09:00 MHDA- 2009/11/05 06:00 CRDT- 2009/08/05 09:00 PHST- 2009/08/05 09:00 [entrez] PHST- 2009/08/05 09:00 [pubmed] PHST- 2009/11/05 06:00 [medline] AID - JST.JSTAGE/internalmedicine/48.2366 [pii] AID - 10.2169/internalmedicine.48.2366 [doi] PST - ppublish SO - Intern Med. 2009;48(15):1255-62. doi: 10.2169/internalmedicine.48.2366. Epub 2009 Aug 3.